Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naive (TN) Mantle Cell Lymphoma (MCL): 2-Year Safety and Efficacy Analysis
Acalabrutinib;Rituximab;Venetoclax
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naive (TN) Mantle Cell Lymphoma (MCL): 2-Year Safety and Efficacy Analysis ### Output: Acalabrutinib;Rituximab;Venetoclax